Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)

v3.22.1
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Common stock warrants    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 18,410,000,000 0
Earnout Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 3,510,405,000 0
Unvested RSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 3,268,105 0